As of October 5, 2026, MetLife Inc. (MET) is trading at $94.43, with analysts from CleaRank Financial AI and Wall Street consensus maintaining a Buy rating and a median price target of $108.00, suggesting approximately 14.4% upside potential from current levels. The stock recently beat earnings per share estimates for the quarter ending June 2026 by 6.11%, accompanied by a positive stock price reaction of 3.83%, which signals underlying operational strength despite trading below its 50-day average. MetLife offers shareholders a dividend yield of approximately 2.46%, providing a modest income stream, though insider activity shows a net selling pressure with $3.8 million in sales reported and no recent purchases, indicating a lack of strong insider conviction. Historical performance data indicates that a $10,000 investment in MET since October 2016 would be worth about $23,038 today, significantly underperforming the S&P 500 benchmark which reached approximately $35,693 over the same period. CleaRank's Monte Carlo simulations project a base case price near $128 for MET by 2030, representing a 1.4x return from today's price assuming no dividends are reinvested, with a downside path ending near $59.36. These projections are based on statistical simulations of historical volatility and drift rather than specific price targets, highlighting the uncertainty inherent in long-term equity forecasting for the insurance sector.